Cargando…

Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection

BACKGROUND: RT-qPCR is the reference test for identification of active SARS-CoV-2 infection, but is associated with diagnostic delay. Antigen detection assays can generate results within 20 min and outside of laboratory settings. Yet, their diagnostic test performance in real life settings has not b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gremmels, Hendrik, Winkel, Beatrice M.F., Schuurman, Rob, Rosingh, Andert, Rigter, Nicolette A.M., Rodriguez, Olga, Ubijaan, Johan, Wensing, Annemarie M.J., Bonten, Marc J.M., Hofstra, L.Marije
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832943/ https://www.ncbi.nlm.nih.gov/pubmed/33521610 http://dx.doi.org/10.1016/j.eclinm.2020.100677

Ejemplares similares

Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study
por: Winkel, Beatrice, et al.
Publicado: (2021)

Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Evaluation of the Abbott Panbio(™) COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care
por: Eikelenboom-Boskamp, Andrea, et al.
Publicado: (2023)

Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests
por: Batty, Mitchell, et al.
Publicado: (2023)

A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
por: Batra, Rahul, et al.
Publicado: (2020)

Evaluation of the Abbott Panbio(TM) COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians
por: Shaw, Julie L V, et al.
Publicado: (2021)

Evaluation of the performance of Abbott Panbio™ COVID-19 antigen rapid diagnostic test for the detection of severe acute respiratory syndrome coronavirus 2 at Harar, Eastern Ethiopia
por: Teklemariam, Zelalem, et al.
Publicado: (2023)

The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2—Evaluation of the accuracy and ease-of-use
por: Krüger, Lisa J., et al.
Publicado: (2021)

Evaluation of the diagnostic performance of PanbioTM Abbott SARS-CoV-2 rapid antigen test for the detection of COVID-19 from suspects attending ALERT center
por: Ashagre, Wondimu, et al.
Publicado: (2022)

Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays
por: Boler, Michael, et al.
Publicado: (2023)

Dr. Frank Abbott
por: Tension, W. D., et al.
Publicado: (1897)

Compendio Abbott.
Publicado: (1953)

Abbott’s at the Top
Publicado: (1909)

Abbott’s Scissors
Publicado: (1883)

Abbott’s Scissors
Publicado: (1884)

Dr. George Abbott
Publicado: (1911)

Abbott’s History of the Rebellion
Publicado: (1863)

Professor Frank Abbott
Publicado: (1897)

Professor Frank Abbott
Publicado: (1897)

Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses
por: Marije Hofstra, Laura, et al.
Publicado: (2014)

Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
por: Hofstra, Laura Marije, et al.
Publicado: (2014)

High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients
por: Hofstra, L. Marije, et al.
Publicado: (2017)

Evaluación de la validez del Ag PANBIO-COVID19 de Abbott en el diagnóstico de la infección por SARS-CoV-2 en pacientes asintomáticos o con infección leve
por: Gras-Valenti, Paula, et al.
Publicado: (2021)

The Abbott TDx evaluated for T-uptake
por: Harff, G. A.
Publicado: (1984)

Frank Abbott, M. D.
Publicado: (1897)

Frank Abbott, M.D.
Publicado: (1897)

Death of Dr. F. W. Abbott
Publicado: (1901)

Frank W. Abbott, M. D.
por: Abbott, Frank W.
Publicado: (1894)

Resolutions of Respect: Dr. Frank Abbott
Publicado: (1897)

Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test
por: Alemany, Andrea, et al.
Publicado: (2021)

Drs. Frank Abbott and L. G. Ingersoll
por: Brophy, Truman W., et al.
Publicado: (1898)

Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population
por: Gallardo-Alfaro, Laura, et al.
Publicado: (2023)

Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

Comparison of Performance of Serum and Plasma in Panbio Dengue and Japanese Encephalitis Virus Enzyme-Linked Immunosorbent Assays
por: Blacksell, Stuart D., et al.
Publicado: (2012)

Experience with Panbio™ rapid antigens test device for the detection of SARS-CoV-2 in nursing homes()
por: Domínguez Fernández, Mercedes, et al.
Publicado: (2022)

Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2
por: Ngo Nsoga, Marie Thérèse, et al.
Publicado: (2021)

Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19
por: Fenollar, Florence, et al.
Publicado: (2021)

Evaluation of the Panbio Leptospira IgM ELISA among Outpatients Attending Primary Care in Southeast Asia
por: Dhawan, Sandhya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4rfl984vg1ebhn591c5dr4f8bh